All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

3,685

Reset

3,685 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • CRN09682Phase 21 trial

    Crinetics Pharmaceuticals Inc. · SST2-positive Neuroendocrine Neoplasms, Neuroendocrine Tumors, Neuroendocrine Neoplasm

  • CRT-402Phase 21 trial

    Myeloid Therapeutics · Autoimmune Diseases, Systemic Lupus Erythematosus, Systemic Scleroderma

  • CS-002Phase 21 trial

    Applied Biology, Inc. · Canities, Grey Hair

  • CS2009Phase 21 trial

    CStone Pharmaceuticals · Advanced Solid Tumors

  • CS32582Phase 21 trial

    Chipscreen Biosciences, Ltd. · Plaque Psoriasis

  • CS5006Phase 21 trial

    CStone Pharmaceuticals · Advanced Solid Tumors

  • CSG452Phase 21 trial

    Kowa Research Institute, Inc. · NASH

  • CSL787Phase 21 trial

    CSL Behring · Non-cystic Fibrosis Bronchiectasis

  • CSL889Phase 21 trial

    CSL Behring · Sickle Cell Disease Vaso-occlusive Crisis

  • CST-3056Phase 21 trial

    CuraSen Therapeutics, Inc. · Neurogenic Orthostatic Hypotension

  • CSTI-500Phase 21 trial

    ConSynance Therapeutics · Prader-Willi Syndrome

  • CT041Phase 21 trial

    CARsgen Therapeutics Co., Ltd. · Gastric Cancer, Pancreatic Cancer

  • CT071Phase 21 trial

    CARsgen Therapeutics Co., Ltd. · Multiple Myeloma, Primary Plasma Cell Leukemia

  • CT3001Phase 21 trial

    Crossignal Therapeutics, Inc. · Solid Tumor, Adult, Colorectal Cancer, Pancreatic Ductal Adenocarcinoma

  • CT7439Phase 21 trial

    Carrick Therapeutics Limited · Solid Malignancies

  • CTAP101Phase 21 trial

    OPKO Health, Inc. · CKD Stage 3, CKD Stage 4, Secondary Hyperparathyroidism

  • CTH120Phase 21 trial

    Connecta Therapeutics, S.L. · Fragile X Syndrome (FXS), Fragile X Syndrome

  • CTO1681Phase 21 trial

    CytoAgents, Inc. · Cytokine Release Syndrome

  • CTS3497Phase 21 trial

    CytosinLab Therapeutics Co., Ltd. · Solid Tumor, Lymphoma

  • CTX-471Phase 21 trial

    Compass Therapeutics · Neuroendocrine Neoplasm, Neuroendocrine Carcinomas, Neuroendocrine Tumors

  • CTX-712Phase 21 trial

    Chordia Therapeutics, Inc. · Acute Myeloid Leukemia, Myelodysplastic Syndromes

  • CTX340Phase 21 trial

    CRISPR Therapeutics AG · Hypertension

  • CTX460Phase 21 trial

    CRISPR Therapeutics · Alpha-1 Antitrypsin Deficiency (AATD)

  • CU01-1001Phase 21 trial

    Curacle Co., Ltd. · Diabetic Nephropathies

  • CU06-1004Phase 21 trial

    Curacle Co., Ltd. · DME, Diabetic Macular Edema, Diabetic Macular Edema (DME)

  • CX-011Phase 21 trial

    CarthroniX, Inc. · Osteoarthritis of the Knees

  • CYB004Phase 21 trial

    Cybin IRL Limited · Generalized Anxiety Disorder

  • CYT-0851Phase 21 trial

    Cyteir Therapeutics, Inc. · Malignancy, Non-hodgkin Lymphoma, Multiple Myeloma

  • CYT-1010Phase 21 trial

    Cytogel Pharma, LLC · Acute Postoperative Pain, Dental Pain

  • DA-020Phase 21 trial

    Applied Biology, Inc. · Chemotherapy Induced Alopecia, Chemotherapy Side Effects

  • DA-2811Phase 21 trial

    Dong-A ST Co., Ltd. · Diabete Mellitus

  • DA-2811-CPhase 21 trial

    Dong-A ST Co., Ltd. · Diabete Mellitus

  • DA-4505Phase 21 trial

    Dong-A ST Co., Ltd. · Locally Advanced or Metastatic Solid Tumors

  • DanvatirsenAZD9150Phase 21 trial

    AstraZeneca · Non-Small Cell Lung Cancer

  • DaplusiranTomligisiranPhase 21 trial

    GSK · Chronic Hepatitis B Virus Infection, Hepatitis B

  • DAT-2645Phase 21 trial

    Danatlas Pharmaceuticals Co., Ltd · Advanced or Metastatic Ovarian Cancer

  • DaxdilimabHZN-7734Phase 21 trial

    Amgen · Idiopathic Inflammatory Myositis

  • DB-1310Phase 21 trial

    DualityBio Inc. · Advanced Solid Tumor

  • DB-1324Phase 21 trial

    DualityBio Inc. · Gastrointestinal Cancer

  • DB-1419Phase 21 trial

    DualityBio Inc. · Solid Tumor, Adult

  • DB-2304Phase 21 trial

    DualityBio Inc. · Systemic Lupus Erythematosus (SLE) or Cutaneous Lupus Erythematosus

  • DC05F01Phase 21 trial

    Heronova Pharmaceuticals · Solid Tumors, Ovarian Cancer, Small Cell Lung Cancer

  • DCC-3009Phase 21 trial

    Deciphera Pharmaceuticals, LLC · Gastrointestinal Stromal Tumor (GIST)

  • DD01Phase 21 trial

    Neuraly, Inc. · NAFLD, NASH

  • Debio 1562MPhase 21 trial

    Debiopharm International SA · Acute Myeloid Leukemia

  • Debio 4228Phase 21 trial

    Debiopharm International SA · Prostate Cancer

  • Decoy20Phase 21 trial

    Indaptus Therapeutics, Inc · Solid Tumor, Adult, HCC - Hepatocellular Carcinoma, CRC (Colorectal Cancer)

  • DES-1357Phase 21 trial

    D. E. Shaw Research, LLC · Metastatic Colorectal Cancer (CRC)

  • DF1001Phase 21 trial

    Dragonfly Therapeutics · Solid Tumor, Adult

  • DF9001Phase 21 trial

    Dragonfly Therapeutics · Solid Tumor, Adult

NewerPage 50 of 74Older

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.